Phase III cardiac rehabilitation improves left ventricular ejection fraction in patients with coronary artery disease and mildly reduced ejection fraction after percutaneous coronary intervention
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: BACKGROUND: Exercise-based cardiac rehabilitation (ExCR) is standard for secondary prevention in coronary artery disease (CAD), yet its efficacy in patients with heart failure with mildly reduced ejection fraction (HFmrEF) after percutaneous coronary intervention (PCI) remains unclear. METHODS: In this single-center RCT, 120 stable CAD patients with HFmrEF (LVEF 40-49%) post-PCI were randomized 1:1 to receive either guideline-directed medical therapy (GDMT) plus a 52-week structured ExCR program (intervention) or GDMT alone (control). Primary outcomes-LDL-C, TG, LVEF, and LVEDD-were assessed at 4, 12, 24, and 52 weeks. Linear Mixed Models analyzed longitudinal intervention effects. RESULTS: A significant Group × Time interaction was observed for LVEF (p = .032), indicating superior recovery in the ExCR group. At 52 weeks, the ExCR group showed greater improvement in LVEF (+5.0% vs. +4.0%, p = .023) and greater reduction in LDL-C (-1.43 mmol/L vs. -1.04 mmol/L, p = .030) versus control. No between-group differences were found in TG or LVEDD. CONCLUSIONS: A 52-week structured ExCR program significantly enhances cardiac recovery and lipid control in HFmrEF patients post-PCI, providing incremental benefits beyond GDMT alone. Sustained ExCR should be considered essential in comprehensive management for this population.
Authors: Mei-Lian Cai, Wu-Xiang Shi, Jing Li, Tao Li, Wei Zhang, Chuang-Biao Lin, Xin-Yun Wang, Yu-Ting Huang, Xin-Min Qing
Institutions: Guilin Medical University, Chinese People's Liberation Army
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cardiac rehabilitation, exercise-based cardiac rehabilitation, heart failure with mildly reduced ejection fraction, coronary artery disease, percutaneous coronary intervention, left ventricular ejection fraction, LDL cholesterol, triglycerides, left ventricular end-diastolic diameter, guideline-directed medical therapy, secondary prevention
Open Access status: hybrid
Estimated APC paid: $3,970
Funder: Guilin Medical University
Awards: G6722484249, G8464199235
OpenAlex ID: W7128360561
